2025-03-18 08:54:04 am | Source: ARETE Securities Ltd
Stock Insights : Bajaj Finserv Ltd , Info Edge Ltd, Ircon International Ltd, JK Paper Ltd, PC Jeweller Ltd - ARETE Securities Ltd
Stock Insights : Bajaj Finserv Ltd , Info Edge Ltd, Ircon International Ltd, JK Paper Ltd, PC Jeweller Ltd - ARETE Securities Ltd

The markets are expected to open marginally higher today as trends in GIFT NIFTY indicate a positive start for the broader index after Nifty closed 111 points higher at 22,508 on Monday.

Bajaj Finserv Ltd:

The company approved the acquisition of Allianz SE’s 26% stake in its insurance JVs, raising its holding to 75.01%, subject to regulatory approvals.

EFC (I) Ltd:

The company acquired a 26,500 sq. ft. commercial office space in Pune, strengthening its serviced office portfolio.

Indian Renewable Energy Development Agency Ltd:

The company increased its FY 2024-25 borrowing limit by Rs.5,000 crore to Rs.29,200 crore through multiple funding sources.

Info Edge Ltd:

The company’s subsidiary, Jeevansathi, invested Rs.30 crore in Aisle Network Private Ltd. to support its working capital needs.

Ircon International Ltd:

The company, in a JV (26% stake), secured a domestic EPC contract for constructing a new Secretariat Complex in Shillong, Meghalaya, with a 36-month execution timeline.

JK Paper Ltd:

The company faced a worker strike at its Gujarat plant, reducing production by 20%; discussions are ongoing to resolve the issue.

Muthoot Finance Ltd:

The company’s issuer credit rating was upgraded by S&P Global Ratings from ‘BB/B’ to ‘BB+/B’.

PC Jeweller Ltd:

The company allotted 51.71 crore equity shares at Rs.29.20 per share to settle outstanding debts with consortium lenders.

Rites Ltd:

The company received an addendum to its contract with Ntokoto Rail Holdings for supplying and commissioning overhauled Cape Gauge ALCO Diesel Electric Locomotives, increasing the order value to $10.80 million.

Shilpa Medicare Ltd:

The company signed a term sheet with Switzerland-based mAbTree Biologics AG for co-developing, manufacturing, and commercializing a new biological entity for oncology treatment.

 

 

Please refer disclaimer at http://www.aretesecurities.com/

SEBI Regn. No.: INM0000127

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here